(Q72898835)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8359620%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

title

Autoimmunity during alpha-interferon therapy for chronic hepatitis C (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8359620%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

1 reference

1 reference

M Yoshikawa

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8359620%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

T Sakamoto

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8359620%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

A Mitoro

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8359620%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

T Mochi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8359620%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

H Tsujii

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8359620%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

M Koizumi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8359620%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

H Yoshiji

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8359620%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

Y Sakaguchi

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8359620%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

H Fukui

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8359620%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

H Nakano

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8359620%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

publication date

1 May 1993

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8359620%20AND%20SRC:MED&resulttype=core&format=json

Gastroenterologia Japonica

30 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8359620%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

volume

28 Suppl 5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8359620%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

page(s)

109-114

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8359620%20AND%20SRC:MED&resulttype=core&format=json

Acute exacerbation of liver disease during interferon alfa therapy for chronic hepatitis C

30 October 2019

cites work

1 reference

12 December 2020

Development of thyroid disease during therapy of chronic viral hepatitis with interferon alfa

1 reference

12 December 2020

Decrease in Serum Hepatitis C Viral RNA during Alpha-Interferon Therapy for Chronic Hepatitis C

1 reference

12 December 2020

Hepatitis C viraemia in adults with type 2 autoimmune hepatitis.

1 reference

12 December 2020

Identification of hepatitis A virus as a trigger for autoimmune chronic hepatitis type 1 in susceptible individuals.

1 reference

12 December 2020

Antibodies to hepatitis C virus in autoimmune liver disease: evidence for geographical heterogeneity

1 reference

12 December 2020

Non-A, non-B hepatitis specific antibodies directed at host-derived epitope: implication for an autoimmune process.

1 reference

12 December 2020

Interferon-induced chronic active hepatitis?

1 reference

12 December 2020

Development of systemic lupus erythematosus after interferon therapy for chronic myelogenous leukemia

1 reference

12 December 2020

Type 2 autoimmune hepatitis and hepatitis C virus infection

1 reference

12 December 2020

Exacerbation of symptoms of autoimmune disease in patients receiving alpha-interferon therapy

1 reference

12 December 2020

Auto-immune thrombocytopenia related to interferon therapy

1 reference

12 December 2020

Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial

1 reference

12 December 2020

Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial

1 reference

12 December 2020

Treatment of chronic type B hepatitis with recombinant alpha-interferon induces autoantibodies not specific for autoimmune chronic hepatitis

1 reference

12 December 2020

Psoriasis and alpha-interferon

1 reference

12 December 2020

Thyroid autoimmunity in patients on long term therapy with leukocyte-derived interferon

1 reference

12 December 2020

Treatment of chronic non-A,non-B hepatitis with recombinant human alpha interferon. A preliminary report

1 reference

12 December 2020

Alpha-interferon and immune hemolytic anemia

1 reference

12 December 2020

Regulation of interleukin 1 production by alpha and beta interferons: evidence for both direct and indirect enhancement

1 reference

12 December 2020

Effects of interferon on antibody synthesis in vitro

1 reference

12 December 2020

Regulation of human peripheral blood monocyte DR antigen expression in vitro by lymphokines and recombinant interferons

1 reference

12 December 2020

Augmentation by interferon of human natural and antibody-dependent cell-mediated cytotoxicity

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02989219

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8359620%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

1 reference